通过增强合成途径,阻断降解途径和增加前体供应,有效地从Bacillus amyloliquefaciens生产精氨酸
Ziyue Zhao1, Ailing Guo1, Dian Zou1
1National Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan 430070, China.
Journal of biotechnology
|December 8, 2024
概括
这项研究设计了Bacillus amyloliquefaciens,用于使用可再生生物质高效生产精氨酸. 优化的菌株实现了高精氨酸标位,证明了可持续的生物生产潜力.
科学领域:
- 微生物生物技术 微生物生物技术
- 代谢工程是代谢工程.
- 生物生产是一种生物生产.
背景情况:
- 精子胺在食品和医疗行业具有显著的潜力.
- 开发可持续的精氨酸生产方法至关重要.
研究的目的:
- 建设一个高效的Bacillus amyloliquefaciens细胞工厂,用于精子胺的生产.
- 使用可再生生物质资源优化精氨酸产量.
主要方法:
- 通过优化 speB 基因和促进剂来改造了 Bacillus amyloliquefaciens.
- 通过基因淘汰 (yobN,bltD) 和前体供应 (speD过度表达) 增强了精子素合成.
- 利用可再生资源,如粉和羽毛粉进行发酵.
主要成果:
- 确定 speB 为精子胺合成的最佳.
- 在基因淘汰后达到115.96 mg/L的精子胺标位.
- 通过前体增强,增加了精氨酸标位至277.47 mg/L.
- 使用优化生物质,达到最大的精胺标位为588.10 mg/L.
结论:
- 成功构建了一种高效的产精氨酸的B. amyloliquefaciens菌株.
- 从西洛斯和羽毛粉中证明了可持续的精子胺生产.
- 代谢工程策略为工业性精氨酸生物生产提供了一个可行的途径.
相关概念视频
Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Amino Acid Biosynthetic Pathways
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Biopesticides
Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...


